DTL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.447200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.706400E-01
Normal-vs-Stage2
2.102600E-01
Normal-vs-Stage3
7.185200E-01
Normal-vs-Stage4
4.195000E-01
Stage1-vs-Stage2
6.052000E-01
Stage1-vs-Stage3
4.866800E-01
Stage1-vs-Stage4
9.619800E-01
Stage2-vs-Stage3
2.612800E-01
Stage2-vs-Stage4
7.128000E-01
Stage3-vs-Stage4
5.187000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.634600E-01
Normal-vs-AfricanAmerican
1.451760E-01
Normal-vs-Asian
1.700780E-01
Caucasian-vs-AfricanAmerican
8.908400E-01
Caucasian-vs-Asian
4.320000E-01
AfricanAmerican-vs-Asian
5.048400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.892800E-01
Normal-vs-Female
2.068000E-01
Male-vs-Female
3.884000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.604400E-01
Normal-vs-Age(41-60Yrs)
2.673800E-01
Normal-vs-Age(61-80Yrs)
2.392800E-01
Normal-vs-Age(81-100Yrs)
9.890400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.371990E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.361700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.604200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.054800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.860400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.629600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.649400E-01
Normal-vs-Daily Drinker
3.040400E-01
Normal-vs-Weekly Drinker
1.850630E-01
Normal-vs-Occasional Drinker
3.292400E-01
Normal-vs-Social Drinker
3.096000E-01
Non Drinker-vs-Daily Drinker
2.599800E-01
Non Drinker-vs-Weekly Drinker
5.117800E-01
Non Drinker-vs-Occasional Drinker
8.470400E-01
Non Drinker-vs-Social Drinker
8.743200E-01
Daily Drinker-vs-Weekly Drinker
1.432020E-01
Daily Drinker-vs-Occasional Drinker
3.192200E-01
Daily Drinker-vs-Social Drinker
4.305000E-01
Weekly Drinker-vs-Occasional Drinker
7.088200E-01
Weekly Drinker-vs-Social Drinker
4.837000E-01
Occasional Drinker-vs-Social Drinker
7.742600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.328000E-01
Normal-vs-Grade 2
7.535600E-01
Normal-vs-Grade 3
7.985400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.616200E-04
Grade 1-vs-Grade 3
2.362300E-04
Grade 1-vs-Grade 4
6.328000E-01
Grade 2-vs-Grade 3
2.723800E-01
Grade 2-vs-Grade 4
7.535600E-01
Grade 3-vs-Grade 4
7.985400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.446200E-01
Normal-vs-NonDiabetic
2.280600E-01
Diabetic-vs-NonDiabetic
1.359180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.646380E-01
Normal-vs-NoPancreatitis
2.884400E-01
Pancreatitis-vs-NoPancreatitis
6.230600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.925600E-01
Normal-vs-N1
2.481800E-01
N0-vs-N1
8.676200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.679900E-02
Normal-vs-TP53-NonMutant
2.343200E-01
TP53-Mutant-vs-TP53-NonMutant
2.0064999999958E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
